Labeling and Characterization of Human GLP-1-Secreting L-cells in Primary Ileal Organoid Culture
Labeling and Characterization of Human GLP-1-Secreting L-cells in Primary Ileal Organoid Culture
复制标题
DOI:
10.1016/j.celrep.2020.107833
复制
发表时间:
2020-06-30
期刊:
影响因子:
8.8
通讯作者:
Gribble, Fiona M.
中科院分区:
文献类型:
--
作者:
Goldspink, Deborah A.;Lu, Van B.;Gribble, Fiona M.
Glucagon-like peptide-1 (GLP-1) from intestinal L-cells stimulates insulin secretion and reduces appetite after food ingestion, and it is the basis for drugs against type-2 diabetes and obesity. Drugs targeting L- and other enteroendocrine cells are under development, with the aim to mimic endocrine effects of gastric bypass surgery, but they are difficult to develop without human L-cell models. Human ileal organoids, engineered by CRISPR-Cas9, express the fluorescent protein Venus in the proglucagon locus, enabling maintenance of live, identifiable human L-cells in culture. Fluorescence-activated cell sorting (FACS)-purified organoid-derived L-cells, analyzed by RNA sequencing (RNA-seq), express hormones, receptors, and ion channels, largely typical of their murine counterparts. L-cells are electrically active and exhibit membrane depolarization and calcium elevations in response to G-protein-coupled receptor ligands. Organoids secrete hormones in response to glucose and other stimuli. The ability to label and maintain human L-cells in organoid culture opens avenues to explore L-cell function and develop drugs targeting the human enteroendocrine system.